Close Menu
  • Home
  • Opinion
  • Region
    • Africa
    • Asia
    • Europe
    • Middle East
    • North America
    • Oceania
    • South America
  • AI & Machine Learning
  • Robotics & Automation
  • Space & Deep Tech
  • Web3 & Digital Economies
  • Climate & Sustainability Tech
  • Biotech & Future Health
  • Mobility & Smart Cities
  • Global Tech Pulse
  • Cybersecurity & Digital Rights
  • Future of Work & Education
  • Trend Radar & Startup Watch
  • Creator Economy & Culture
What's Hot

Merck to Purchase Cidara for $9.2B, Bolstering Antiviral Pipeline 

November 16, 2025

Mādin’s Nick Valenti On What Makes Creator Manufacturers Break By

November 16, 2025

Korea – U.S. Joint Truth Sheet Secures Tariff Readability for Autos, Semiconductors, and Prescription drugs – KoreaTechDesk

November 16, 2025
Facebook X (Twitter) Instagram LinkedIn RSS
NextTech NewsNextTech News
Facebook X (Twitter) Instagram LinkedIn RSS
  • Home
  • Africa
  • Asia
  • Europe
  • Middle East
  • North America
  • Oceania
  • South America
  • Opinion
Trending
  • Merck to Purchase Cidara for $9.2B, Bolstering Antiviral Pipeline 
  • Mādin’s Nick Valenti On What Makes Creator Manufacturers Break By
  • Korea – U.S. Joint Truth Sheet Secures Tariff Readability for Autos, Semiconductors, and Prescription drugs – KoreaTechDesk
  • No Man, No Downside: How Suki Baroudi Is Redefining Egypt’s Woodworking World
  • Evaluating the High 4 Agentic AI Browsers in 2025: Atlas vs Copilot Mode vs Dia vs Comet
  • TARS Robotic from Interstellar Comes Alive, Turns into TARS3D
  • CISA Flags Important WatchGuard Fireware Flaw Exposing 54,000 Fireboxes to No-Login Assaults
  • The Quickest (68k) Macintosh May Not Be An Amiga Anymore
Sunday, November 16
NextTech NewsNextTech News
Home - North America - Forward of Q2 outcomes, is Tantalus Methods a purchase?
North America

Forward of Q2 outcomes, is Tantalus Methods a purchase?

NextTechBy NextTechJuly 31, 2025No Comments3 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
Follow Us
Google News Flipboard
Forward of Q2 outcomes, is Tantalus Methods a purchase?
Share
Facebook Twitter LinkedIn Pinterest Email


Beacon Securities analyst Gabriel Leung famous in a July 30 report that Tantalus Methods (Tantalus Methods Holding Inventory Quote, Chart, Information, Analysts, Financials TSXV:GRID) is about to report its Q2 2025 outcomes after market shut on Wednesday, August 6. He’s sustaining a “Purchase” score and C$5.50 goal value, which relies on a 3.5x EV/Gross sales a number of, in step with friends.

Leung expects Q2 income of $12.2 million and an EBITDA lack of $214,000, in comparison with consensus estimates of $12.3 million in income and a $100,000 EBITDA loss. His forecast displays roughly 13% year-over-year natural progress, down from 27% progress in Q1. EBITDA can be projected to say no from $316,000 in Q1, remaining flat on a year-over-year foundation.

Tantalus Methods, based mostly in Vancouver, offers ‘good’ grid know-how to round 320 public energy and electrical co-op utilities.

“On the decision, we count on the main target will probably be across the firm’s TRUSense pipeline (recall that final quarter there have been 33 utilities on trial deployments), together with a progress replace on the not too long ago introduced TRUSense deployment with EPB in Chattanooga,” he mentioned. “We additionally count on commentary round any influence on buyer choice cycles stemming from U.S. tariffs.

“Recall that prospects needed to take care of 10% base tariffs throughout Q2 (of which Tantalus absorbed 5%).”

Tantalus might count on to face greater tariffs following a newly negotiated deal between the U.S. and the Philippines, the place it manufactures its {hardware}. Tariffs are projected to rise to 19%, with the corporate persevering with to soak up 5% whereas passing the remaining 14% on to prospects.

“We consider that Tantalus’ utility prospects have been making ready for the tariff headwinds,” Leung mentioned. “As such, we don’t anticipate any materials influence on present contracts/deployments, though we’ll see if there may be any potential influence on offers within the pipeline.”

Leung expects Tantalus to submit $1.3-million in Adjusted EBITDA on $51.5-million in income for fiscal 2025, enhancing to $2.6-million and $59.5-million, respectively, in 2026.

-30-

Nick Waddell

Founding father of Cantech Letter

Cantech Letter founder and editor Nick Waddell has lived in 5 Canadian provinces and is happy with his nation’s usually ignored contributions to the world of science and know-how. Waddell takes an everyday shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications comparable to Canadian Enterprise and Enterprise Insider.

Loading extra…



Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s tendencies at this time: learn extra, subscribe to our publication, and turn into a part of the NextTech group at NextTech-news.com

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
NextTech
  • Website

Related Posts

TARS Robotic from Interstellar Comes Alive, Turns into TARS3D

November 16, 2025

A Nearer Have a look at Valve’s Steam Body, the VR Headset That Might Revolutionize Wi-fi Play

November 16, 2025

Honda’s V3R 900 Prototype Rolls Out a Contemporary Tackle Energy

November 16, 2025
Add A Comment
Leave A Reply Cancel Reply

Economy News

Merck to Purchase Cidara for $9.2B, Bolstering Antiviral Pipeline 

By NextTechNovember 16, 2025

Merck & Co. has agreed to accumulate Cidara Therapeutics for about $9.2 billion, the businesses…

Mādin’s Nick Valenti On What Makes Creator Manufacturers Break By

November 16, 2025

Korea – U.S. Joint Truth Sheet Secures Tariff Readability for Autos, Semiconductors, and Prescription drugs – KoreaTechDesk

November 16, 2025
Top Trending

Merck to Purchase Cidara for $9.2B, Bolstering Antiviral Pipeline 

By NextTechNovember 16, 2025

Merck & Co. has agreed to accumulate Cidara Therapeutics for about $9.2…

Mādin’s Nick Valenti On What Makes Creator Manufacturers Break By

By NextTechNovember 16, 2025

Influencers aren’t simply promoting merchandise anymore. They’re constructing firms anchored in…

Korea – U.S. Joint Truth Sheet Secures Tariff Readability for Autos, Semiconductors, and Prescription drugs – KoreaTechDesk

By NextTechNovember 16, 2025

Korea and the US have finalized a Joint Truth Sheet that resets…

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

NEXTTECH-LOGO
Facebook X (Twitter) Instagram YouTube

AI & Machine Learning

Robotics & Automation

Space & Deep Tech

Web3 & Digital Economies

Climate & Sustainability Tech

Biotech & Future Health

Mobility & Smart Cities

Global Tech Pulse

Cybersecurity & Digital Rights

Future of Work & Education

Creator Economy & Culture

Trend Radar & Startup Watch

News By Region

Africa

Asia

Europe

Middle East

North America

Oceania

South America

2025 © NextTech-News. All Rights Reserved
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service
  • Advertise With Us
  • Write For Us
  • Submit Article & Press Release

Type above and press Enter to search. Press Esc to cancel.

Subscribe For Latest Updates

Sign up to best of Tech news, informed analysis and opinions on what matters to you.

Invalid email address
 We respect your inbox and never send spam. You can unsubscribe from our newsletter at any time.     
Thanks for subscribing!